• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾司洛尔和拉贝洛尔对豚鼠心脏心功能、冠脉血管活性和心室电生理学的直接作用。

Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts.

机构信息

Department of Cell Physiology, Akita University Graduate School of Medicine, Japan.

出版信息

J Pharmacol Sci. 2012;118(2):255-65. doi: 10.1254/jphs.11202fp. Epub 2012 Feb 1.

DOI:10.1254/jphs.11202fp
PMID:22293301
Abstract

The ultra-short acting, selective β(1)-adrenergic antagonists landiolol and esmolol are widely used perioperatively; however, little is known about their acute direct actions on the heart. The current study utilized the Langendorff perfused heart system to measure changes in cardiac function and hemodynamics in response to each drug. Furthermore, electrophysiological analysis was performed on isolated ventricular myocytes. Direct application of esmolol significantly decreased systolic left ventricular pressure and heart rate at concentrations > 10 µM, while it dose-dependently increased coronary perfusion pressure. Esmolol also shortened the action potential duration (APD) in a concentration-dependent manner, an action maintained even when the delayed rectifier K(+) current or ATP sensitive K(+) current was blocked. Moreover, esmolol inhibited both the inward rectifier K(+) current (I(K1)) and the L-type Ca(2+) current (I(CaL)) and increased the outward current dose-dependently. In contrast, landiolol had minimal cardiac effects. In the Kyoto Model computer simulation, inhibition of either I(K1) or I(CaL) alone failed to shorten the APD; however, an additional increase in the time-independent outward current caused shortening of the APD, equal to that induced by esmolol. In conclusion, esmolol directly inhibits cardiac performance significantly more so than landiolol, an effect revealed to be at least in part mediated by esmolol-induced APD shortening.

摘要

超短效、选择性β(1)-肾上腺素能拮抗剂拉贝洛尔和艾司洛尔在围手术期广泛应用;然而,关于其对心脏的急性直接作用知之甚少。本研究利用 Langendorff 灌流心脏系统测量了心脏功能和血流动力学对每种药物的变化。此外,还对分离的心室肌细胞进行了电生理分析。艾司洛尔的直接应用显著降低了收缩压左心室压和心搏率在浓度>10 µM,而它浓度依赖性地增加冠状动脉灌注压。艾司洛尔还缩短了动作电位时程(APD),这种作用在阻断延迟整流钾电流(I(K+))或ATP 敏感钾电流(I(KATP))时仍然存在。此外,艾司洛尔抑制内向整流钾电流(I(K1))和 L 型钙电流(I(CaL)),并呈浓度依赖性增加外向电流。相比之下,拉贝洛尔对心脏的影响很小。在京都模型计算机模拟中,单独抑制 I(K1)或 I(CaL)均不能缩短 APD;然而,非时相外向电流的增加导致 APD 缩短,与艾司洛尔诱导的 APD 缩短相当。总之,艾司洛尔对心脏功能的直接抑制作用明显大于拉贝洛尔,这种作用至少部分是由艾司洛尔诱导的 APD 缩短介导的。

相似文献

1
Direct effects of esmolol and landiolol on cardiac function, coronary vasoactivity, and ventricular electrophysiology in guinea-pig hearts.艾司洛尔和拉贝洛尔对豚鼠心脏心功能、冠脉血管活性和心室电生理学的直接作用。
J Pharmacol Sci. 2012;118(2):255-65. doi: 10.1254/jphs.11202fp. Epub 2012 Feb 1.
2
In rabbits, landiolol, a new ultra-short-acting beta-blocker, exerts a more potent negative chronotropic effect and less effect on blood pressure than esmolol.在兔子身上,新型超短效β受体阻滞剂兰地洛尔比艾司洛尔具有更强的负性变时作用,而对血压的影响较小。
Can J Anaesth. 2001 Nov;48(10):985-9. doi: 10.1007/BF03016588.
3
Landiolol has a less potent negative inotropic effect than esmolol in isolated rabbit hearts.在离体兔心脏中,拉地洛尔的负性肌力作用比艾司洛尔弱。
J Anesth. 2008;22(4):361-6. doi: 10.1007/s00540-008-0640-4. Epub 2008 Nov 15.
4
The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.短效β1肾上腺素能受体拮抗剂艾司洛尔和兰地洛尔可抑制七氟醚麻醉期间气管插管时的脑电双频指数反应。
Anesth Analg. 2005 Mar;100(3):733-737. doi: 10.1213/01.ANE.0000154441.22654.11.
5
Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.单次静脉注射拉地洛尔和艾司洛尔:健康白种人群药代动力学和药效学特征比较
Eur J Clin Pharmacol. 2017 Apr;73(4):417-428. doi: 10.1007/s00228-016-2176-0. Epub 2017 Jan 13.
6
[New ultra-short-acting beta-blockers: landiolol and esmolol--the effects on cardiovascular system].新型超短效β受体阻滞剂:兰地洛尔和艾司洛尔——对心血管系统的影响
Masui. 2006 Jul;55(7):841-8.
7
Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity.β1 选择性肾上腺素能拮抗剂兰地洛尔和艾司洛尔可安全用于气道高反应性患者。
Heart Lung. 2009 Jan-Feb;38(1):48-55. doi: 10.1016/j.hrtlng.2008.01.002. Epub 2008 Sep 11.
8
Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.β-肾上腺素能受体拮抗剂兰地洛尔和艾司洛尔的比较:受体选择性、部分激动作用及药物伴侣作用
J Pharmacol Exp Ther. 2016 Oct;359(1):73-81. doi: 10.1124/jpet.116.232884. Epub 2016 Jul 22.
9
Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.兰地洛尔、艾司洛尔和普萘洛尔可保护离体豚鼠心脏免受缺血/再灌注损伤。
Can J Anaesth. 2003 May;50(5):489-94. doi: 10.1007/BF03021062.
10
Pharmacokinetics and Pharmacodynamics of Low-, Intermediate-, and High-Dose Landiolol and Esmolol During Long-Term Infusion in Healthy Whites.健康白人长期输注低、中、高剂量兰地洛尔和艾司洛尔的药代动力学和药效学
J Cardiovasc Pharmacol. 2018 Mar;71(3):137-146. doi: 10.1097/FJC.0000000000000554.

引用本文的文献

1
The Role of Landiolol in Coronary Artery Disease: Insights into Acute Coronary Syndromes, Stable Coronary Artery Disease and Computed Tomography Coronary Angiography.兰地洛尔在冠状动脉疾病中的作用:对急性冠状动脉综合征、稳定型冠状动脉疾病及计算机断层扫描冠状动脉造影的见解
J Clin Med. 2025 Jul 23;14(15):5216. doi: 10.3390/jcm14155216.
2
Comparison of Landiolol and Esmolol on Haemodynamic Responses During Weaning of Intensive Care Unit Patients with Reduced Ejection Fraction after Vascular Surgery.血管手术后射血分数降低的重症监护病房患者撤机期间兰地洛尔与艾司洛尔对血流动力学反应的比较
Card Fail Rev. 2025 May 21;11:e13. doi: 10.15420/cfr.2024.18. eCollection 2025.
3
Landiolol is effective and safe in paediatric supraventricular tachycardia: evidence from a European prospective multicentre open-label phase III study (LANDI-PED).
兰地洛尔治疗小儿室上性心动过速有效且安全:来自一项欧洲前瞻性多中心开放标签III期研究(LANDI-PED)的证据。
Europace. 2025 Feb 5;27(2). doi: 10.1093/europace/euaf025.
4
Hemodynamic and Rhythmologic Effects of Push-Dose Landiolol in Critical Care-A Retrospective Cross-Sectional Study.推注剂量兰地洛尔在重症监护中的血流动力学和节律学效应——一项回顾性横断面研究
Pharmaceuticals (Basel). 2023 Jan 17;16(2):134. doi: 10.3390/ph16020134.
5
Anesthetized guinea pig as a model for drug testing.麻醉豚鼠作为药物测试的模型。
Physiol Res. 2022 Dec 31;71(S2):S211-S218. doi: 10.33549/physiolres.934994.
6
Positive rate-dependent action potential prolongation by modulating potassium ion channels.通过调节钾离子通道实现动作电位时程的正频率依赖性延长。
Physiol Rep. 2022 Jun;10(12):e15356. doi: 10.14814/phy2.15356.
7
Acute rate control in atrial fibrillation: an urgent need for the clinician.心房颤动的急性心率控制:临床医生的迫切需求。
Eur Heart J Suppl. 2022 Jun 13;24(Suppl D):D3-D10. doi: 10.1093/eurheartjsupp/suac022. eCollection 2022 Jun.
8
Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol.多巴酚丁胺改变艾司洛尔的药代动力学和药效学行为。
Cureus. 2020 Dec 22;12(12):e12217. doi: 10.7759/cureus.12217.
9
Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.评估盐酸兰地洛尔在危急情况下治疗心律失常的疗效和安全性:文献综述
Vasc Health Risk Manag. 2020 Apr 3;16:111-123. doi: 10.2147/VHRM.S210561. eCollection 2020.
10
Landiolol in patients with septic shock resident in an intensive care unit (LANDI-SEP): study protocol for a randomized controlled trial.重症监护病房感染性休克患者使用兰地洛尔的研究(LANDI-SEP):一项随机对照试验的研究方案
Trials. 2018 Nov 19;19(1):637. doi: 10.1186/s13063-018-3024-6.